Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization

Nobutaka Kobayashi1, Seiji Miyoshi, Takahide Mikami

  • 1Department of Molecular Oncology, Division of Molecular and Cellular Biology, Institute on Aging and Adaptation, Shinshu University Graduate School of Medicine, Nagano, Japan.

Cancer Research
|September 9, 2010
PubMed

Insights

Stromal hyaluronan (HA) is crucial for recruiting tumor-associated macrophages (TAMs) to the tumor microenvironment. This recruitment is essential for tumor angiogenesis and lymphangiogenesis, highlighting HA's role in tumor progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Stromal cells play a critical role in tumor progression.
  • Molecular signals regulating tumor stroma interactions are not fully understood.
  • Tumor-associated macrophages (TAMs) are key cellular components within the tumor microenvironment.

Purpose of the Study:

  • To investigate the role of stromal hyaluronan (HA) in the recruitment of TAMs.
  • To elucidate the contribution of stroma-derived HA to macrophage mobilization within tumors.
  • To examine the impact of stromal HA deficiency on tumor angiogenesis and lymphangiogenesis.

Main Methods:

  • Conditional gene targeting of the HA synthase 2 (Has2) gene in stromal fibroblasts.
  • Inoculation of Has2 null fibroblasts with tumor cells in nude mice.
  • Assessment of macrophage recruitment, tumor angiogenesis, and lymphangiogenesis.

Main Results:

  • Disruption of the Has2 gene in stromal fibroblasts significantly impaired macrophage recruitment.
  • Stroma-derived HA is essential for intratumoral macrophage mobilization.
  • Deficiency in stromal HA attenuated tumor angiogenesis and lymphangiogenesis.
  • Macrophage recruitment was impaired in conjunction with reduced angiogenesis and lymphangiogenesis.

Conclusions:

  • Stromal hyaluronan (HA) acts as a critical microenvironmental signal for recruiting TAMs.
  • TAM recruitment, mediated by stromal HA, is essential for tumor neovascularization (angiogenesis and lymphangiogenesis).
  • Targeting stromal HA production may represent a therapeutic strategy to inhibit tumor growth by modulating TAM infiltration and angiogenesis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...